SCHEMBL9329206

SCHEMBL9329206

CCC(C(=O)O)c1ccc(C#Cc2ccc3c(c2)C(C)(C)CC(C)(C)S3)cc1

nearest known ligand 0.41

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ RARB P10826 12/20 0.41
▸ RARG P13631 12/20 0.41
▸ RARA P10276 9/20 0.41
▸ CYP3A4 P08684 3/20 0.41
▸ CYP26A1 O43174 2/20 0.41
▸ CRABP2 P29373 1/20 0.41
▸ AKR1C3 P42330 5/20 0.37
▸ AKR1C2 P52895 5/20 0.37
▸ AKR1C1 Q04828 1/20 0.37
▸ PTGS1 P23219 1/20 0.37
▸ HSPA9 P38646 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ ACACB O00763 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9176637 0.80 RARB (0.64) RARBRARGRARACYP3A4CYP26A1
SCHEMBL8558273 0.77 RARA (0.56) RARBRARGRARACYP3A4CYP26A1
SCHEMBL9182226 0.75 RARA (0.43) RARBRARGRARACYP3A4CYP26A1
SCHEMBL8875276 0.74 CYP3A4 (0.45) RARBRARGRARACYP3A4CYP26A1
SCHEMBL8874983 0.73 RARB (0.39) RARBRARGRARACYP3A4CYP26A1
SCHEMBL8876387 0.73 CYP3A4 (0.40) RARBRARGRARACYP3A4CYP26A1
SCHEMBL8875222 0.72 RARA (0.39) RARBRARGRARACYP3A4CYP26A1
SCHEMBL8876089 0.72 CYP3A4 (0.46) RARBRARGRARACYP3A4CYP26A1
SCHEMBL8864928 0.72 RARA (0.41) RARBRARGRARACYP3A4CYP26A1
SCHEMBL9743368 0.72 FFAR1 (0.36) RARBRARGRARACYP3A4CYP26A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5278318-A Acetylation under Friedel Crafts condition ALLERGAN, INC. (US) 1994-01-11 — — US disclosed
WO-1992006084-A1 CHROMANS AND THIOCHROMANS WITH RETINOID-LIKE ACTIVITY ALLERGAN, INC. (US) 1992-04-16 — — WO disclosed
Send feedback